Please note that only presentations that have been approved for sharing by their originators are available online.
SESSION 2
From ICARO to ICARO2
09:30–10:00
From ICARO1 to ICARO2: the radiation oncologist perspective. Eduardo Roseblatt
10:00–10:30
From ICARO1 to ICARO2: the medical physicist perspective. Geoffrey Ibbott
SESSION 3
Global cancer challenges and role of radiotherapy
11:00–11:05
Challenges in cancer control. Mary Evans-Gospodarowicz
11.05–11.10
Sustainability of radiotherapy in LMIC. Alfredo Polo
11.10–11.15
Innovating to meet the demand for RT. David Jaffray
11:15–11:20
Reimbursement in HIC. Yolande Lievens
11:20–11:25
Auditing advanced technologies. David Followill
SESSION 4
SESSION 5A
SESSION 5B
Symposium: Paediatric radiotherapy
12:30–12:55
Paediatric medulloblastoma. Mohamed Zaghloul
12:55–13:20
Benefits of High Technology applied to Paediatric Radiation Oncology. Rosangela Correa Villar
13:20–13:45
Paediatric intraoperative electron radiotherapy: results and innovations. Felipe Calvo
SESSION 6
Requirements for safe and effective transition to new/appropriate technologies
14.00–14.05
14.05–14.10
14.10–14.15
14.15–14.20
SESSION 7
SESSION 8
Education and training
16:00–16:15
IAEA Education and Training activities in Radiotherapy. Giorgia Loreti
16:15–16:25
ESTRO School. Richard Poetter
16:25–16:35
Abstract 140: ICTP, Trieste University, Italian and Croatian Medical Physics: A training opportunity for young physicists from Developing Countries (Proffered Paper). Renato Padovani
16:35–16:45
Abstract 142: Accreditation of Education and Professional Standards of Medical Physicists (Proffered Paper). Kin Yin Cheung
16:45–16:55
Abstract 125: Addressing Global Radiation Medicine Human Resource Gaps Through Educational Innovation (Proffered Paper). Meredith Giuliani
16:55–17:05
17:05–17:15
Abstract 112: Competency-based Education of RTT's in Romania: Changing the Paradigm to Prepare the Future (Proffered Paper). Ioan Valentin Cernea
16:15–17:25
Abstract 100: Competency based education and training in radiation oncology (Proffered Paper). Daniel Scanderbeg